Cargando…

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

SIMPLE SUMMARY: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. More than 90% of UMs harbor mutually exclusive activating mutations in G-proteins. The mutations are early events in UM development and considered to be driver mutations in carcinogenesis. Even after tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terai, Mizue, Shimada, Ayako, Chervoneva, Inna, Hulse, Liam, Danielson, Meggie, Swensen, Jeff, Orloff, Marlana, Wedegaertner, Philip B., Benovic, Jeffrey L., Aplin, Andrew E., Sato, Takami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616238/ https://www.ncbi.nlm.nih.gov/pubmed/34830903 http://dx.doi.org/10.3390/cancers13225749

Ejemplares similares

Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2020)

Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
por: Sugase, Takahito, et al.
Publicado: (2020)

Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Seedor, Rino S., et al.
Publicado: (2021)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
por: Ohara, Masahiro, et al.
Publicado: (2021)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
por: Chua, Vivian, et al.
Publicado: (2019)

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
por: Han, Anna, et al.
Publicado: (2023)

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
por: Terai, Mizue, et al.
Publicado: (2015)

An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis
por: Seedor, Rino S., et al.
Publicado: (2020)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
por: Wei, Alexander Z., et al.
Publicado: (2022)

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
por: Kageyama, Ken, et al.
Publicado: (2017)

Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases
por: Shields, Carol L., et al.
Publicado: (2021)

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
por: Minor, David R., et al.
Publicado: (2022)

Improved Uveal Melanoma Copy Number Subtypes Including an Ultra–High-Risk Group
por: Lalonde, Emilie, et al.
Publicado: (2022)

Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma
por: Carvajal, Richard D., et al.
Publicado: (2022)

Targeting Oncogenic Gα(q/11) in Uveal Melanoma
por: Lapadula, Dominic, et al.
Publicado: (2021)

Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
por: Orloff, Marlana
Publicado: (2016)

The genetic evolution of metastatic uveal melanoma
por: Shain, A. Hunter, et al.
Publicado: (2019)

Long-Term Survivors with Metastatic Uveal Melanoma
por: Buzzacco, Dominic M, et al.
Publicado: (2012)

Treatment of Metastatic Uveal Melanoma: Systematic Review
por: Rodriguez-Vidal, Cristina, et al.
Publicado: (2020)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
por: Demirci, Hakan, et al.
Publicado: (2013)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
por: Damato, Bertil E., et al.
Publicado: (2019)

Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
por: Fagone, Paolo, et al.
Publicado: (2017)

Molecular profiling of driver events in metastatic uveal melanoma
por: Karlsson, Joakim, et al.
Publicado: (2020)

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)

Darovasertib, a novel treatment for metastatic uveal melanoma
por: Cao, Lei, et al.
Publicado: (2023)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

A novel combinatorial treatment option for metastatic uveal melanoma
por: Shneor, Dudi, et al.
Publicado: (2018)

Improving therapy in metastatic uveal melanoma by understanding prior failures
por: Olson, Daniel J., et al.
Publicado: (2020)

Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
por: Mallone, Fabiana, et al.
Publicado: (2020)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Pals, Jan, et al.
Publicado: (2021)

Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma
por: Modi, Sachin, et al.
Publicado: (2022)

Clinical determinants of long-term survival in metastatic uveal melanoma
por: Koch, Elias A. T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nnp726j20o6flfk6ldmcdb79l5